RT Conference Proceedings T1 Activated protein C consumption and coagulation parameters in severe sepsis and septic shock. A1 Torre-Prados, M de la A1 García-de la Torre, A A1 Trujillano-Fernández, C A1 Pérez-Vacas, J A1 Puerto-Morlán, A A1 Cámara-Sola, E K1 Choque séptico K1 Pruebas de coagulación sanguínea K1 Pronóstico K1 Proteina C K1 Tasa de supervivencia K1 Unidades de cuidados intensivos AB Introduction Activated protein C (APC) deC ciency is prevalent in severe sepsis and septic shock patients. The aim of the study was to relate the anticoagulation activity evaluated by APC with other coagulationparameters adjusted to 28-day mortality.Methods A cohort study of 150 critically ill adults. Age, sex, sources of infection and coagulation markers within 24< hours from severe sepsis or septic shock onset, deC ned according to Surviving Sepsis Campaign (SSC) criteria, were studied. We analyzed APC activity using a hemostasis laboratory analyzer (BCS® XP; Siemens). A descriptive and comparative statistical analysis was performed using SPSS version 15.0 (SPSS Inc., Chicago, IL, USA).Results We analyzed 150 consecutive episodes of severe sepsis (16%) or septic shock (84%) admitted to the UCI. The median age of the study sample was 64 (interquartile range (IQR): 22.30.001). See Figure 1. Conclusion Low levels of PC are associated with poor outcome andseverity in severe sepsis, and it is well correlated with antithrombin III and INR. PB BioMed Central SN 1364-8535 YR 2014 FD 2014-03 LK http://hdl.handle.net/10668/1815 UL http://hdl.handle.net/10668/1815 LA en NO Torre-Prados M de la, García-de la Torre A, Trujillano-Fernández C, Pérez-Vacas J, Puerto-Morlán A, Cámara-Sola E. Activated protein C consumption and coagulation parameters in severe sepsis and septic shock. Critical Care. 2014;18(Suppl. 1):S80-S81 NO Meeting abstract DS RISalud RD Apr 5, 2025